 |
Recombinant Human Alpha-Fetoprotein (rhAFP) |
|---|---|
| Trade Name | |
| Orphan Indication | Myasthenia gravis Myasthenia gravis |
| USA Market Approval | USA |
| USA Designation Date | 2001-02-22 00:00:00 |
| Sponsor | Alpha Cancer Technologies, Inc.;MaRS Discovery District, South Tower, 200-101 College St.;Toronto, Ontario |
Learn more about: